Specialist Updates

Schizophrenia drug gets PBS listing

Lurasidone HCL has been listed on the PBS to treat atypical schizophrenia.

The drug, marketed as Latuda by Servier Laboratories, has been available in the United States since 2011, Canada since 2012 and Europe since 2013.

Psychiatrist Professor David Castle says the availability of lurasidone HCL has been “eagerly anticipated by the psychiatric community”.